03.01.2018
- After two weeks of protest in Israel, generics giant Teva has temporarily taken back about a third of the planned job cuts at its plant in Jerusalem. Original plans called for 340...
15.12.2017
- As had been widely expected, Israel-headquartered Teva Pharmaceuticals – world’s largest generics producer – announced on Dec. 14 it would slash 14,000 jobs, about a quarter of its...
12.09.2017
- US pharmaceutical giant Eli Lilly has announced it will slash 3,500 positions – about 8% of its global 42,000-strong workforce up to the end of 2017. The cuts, part of a scheme to...
31.08.2017
- Three weeks after announcing it would cut 350 jobs at two plants in Israel, generics producer Teva has trimmed the number back to 285. The company said it will only eliminate 65...
08.08.2017
- As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will...
01.02.2017
- Novo Nordisk has announced plans to invest 1 billion Danish kroner ($145 million) over 10 years in a new research center at the University of Oxford, giving a major boost to the UK...
21.11.2016
- A Schulman, the US plastics compounder and distributor, is slashing 60 jobs – mainly in Europe – as it comes to terms with the fallout from last year’s acquisition of compatriot...
03.10.2016
- The world’s biggest insulin producer, Novo Nordisk, has announced plans to cut 1,000 jobs in response to a challenging environment and increased competition, particularly in the US...
